Market Analysis of Veterinary Drug Feed Ingredients - VPi Down
1. Data monitoring, the veterinary drug raw material price index (VPi) on March 2 was 83.49. The domestic veterinary raw material market lacks confidence, and weak demand is transmitted, mostly showing a wait-and-see attitude.
2. In terms of the market, due to the large space for negotiation of offers of mainstream categories recently, the market transaction prices have fallen, and there is still no obvious sign of improvement in downstream demand. The trade channel shipments are still sluggish, and the industry's mentality has turned pessimistic. Secretly ship at low prices to ease risk pressure. The purchasing mentality of mid-stream and downstream users is weak, it is difficult to follow up the firm offer, and the transaction continues to negotiate and compare prices. It is expected that the actual transaction price in the market may continue to be lowered. The trade channel has high enthusiasm for shipments, but the pace of shipments is relatively slow. The wait-and-see sentiment will continue to increase, and the main sales market will still maintain the previous trend.
3. Raw materials for veterinary drugs: The market performance of raw materials for veterinary drugs continues to be poor. Over time, the market has not improved significantly, the downstream demand is not strong, and the market is mainly purchased in low quantities. Negotiated prices of mainstream factories have dropped significantly, and the competitive attitude is obvious, in order to promote market transactions, such as: florfenicol, tilmicosin, tyvalsin, etc. The trade channel maintains a low inventory, and the small and medium-sized orders are mainly purchased and sold.
4. Vitamins: The domestic vitamin market has been weak recently, and the market demand is not strong and shrinking. There are still some inventory positions in the middle and downstream markets. At the current price range of various categories, it is difficult to mobilize the willingness to purchase, and low-volume replenishment is the mainstay. Mainstream factories are willing to support prices, but affected by market expectations, the middle and lower reaches have a strong wait-and-see mood, the real orders are flat, and the profits are low. It is expected that the overall transaction volume will not increase significantly in the short term, and the market may be dominated by loose bargaining transactions, and later pay attention to factory production and delivery.
2026-08-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Market Analysis of Domestic Veterinary Drug Raw Materials in the 34th Week of 2022
-
The Veterinary Drug Industry is Facing a Period of Opportunity for Change, and Leading Animal Health Companies are Expected to Grow Rapidly
-
Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)
-
Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022
-
Week 21 Partial Veterinary Drug Quotes 2
-
Analysis of The Veterinary Drug Raw Material Market in the 21st Week
-
Market Analysis of Veterinary Drug Raw Materials
-
Continue to Crack Down On The Illegal Use of Veterinary Drugs And Additives in 2022
-
Many Factors Affecting The Price Trend of Veterinary Drug Raw Materials
-
Analysis of The Domestic Veterinary Drug Raw Material Market In The Seventh Week of 2022-1
Recommend Reading
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
Polyester Bottle Flakes Surge First, Then Fall Back This Week (June 8–June 12)
-
Fundamental Dual Support, Lithium Carbonate Price Increase Exceeds Expectations
-
Natural Rubber Prices Up 30% Year-on-Year, Short-Term Fluctuations but Long-Term Potential for Further Increases
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Bearish Factors Exhausted, Hydrogen Peroxide Prices Still Have Room to Rise in Late May